{"id":"W4393165834","doi":"10.1016/j.esmoop.2024.102582","title":"3MO Amivantamab plus chemotherapy vs chemotherapy in EGFR-mutant advanced NSCLC after progression on osimertinib: A post-progression analysis of MARIPOSA-2","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; McGill University; Institute of Cancer Research; Montreal General Hospital; BC Cancer Agency","funders":"Janssen Biotech","keywords":"Osimertinib; Chemotherapy; Oncology; Medicine; Internal medicine; Epidermal growth factor receptor; Cancer; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002029213,0.0007600848,0.002153098,0.0004260082,0.0002332014,0.0007962951,0.000653761,0.001075766,0.003082114],"category_scores_gemma":[0.001439486,0.0002791998,0.002820539,0.0004034489,0.0004366103,0.00077857,0.0003607398,0.002634344,0.0003844907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008853982,"about_ca_system_score_gemma":0.001093669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00100435,"about_ca_topic_score_gemma":0.003455968,"domain_scores_codex":[0.998841,0.0006780972,0.00006569602,0.0001177757,0.00008416153,0.0002132849],"domain_scores_gemma":[0.9987462,0.0003812109,0.0002654827,0.00008541326,0.00005035572,0.0004713526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9536343,0.008389816,0.002332505,0.0002347342,0.00137009,0.00004343977,0.00006519576,0.000581654,0.004062546,0.000101207,0.0005281315,0.02865633],"study_design_scores_gemma":[0.2798534,0.6858494,0.0252752,0.00007706292,0.002417862,0.00008698818,0.00006674953,0.002205249,0.00239276,0.0003500656,0.00139348,0.00003170039],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966435,0.001512399,0.0001324822,0.0001943583,0.000109348,0.000328715,0.0003271884,0.00001883793,0.0007331298],"genre_scores_gemma":[0.9959934,0.0009855449,0.0003204098,0.0003240569,0.0001884237,0.0004446418,0.0005830447,0.00001032552,0.001150108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003082114,"threshold_uncertainty_score":0.01073164,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01046002646336001,"score_gpt":0.3808748102738199,"score_spread":0.3704147838104598,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}